Ana Miguel

Ana Miguel

Auto-generated profile, based on publicly available information

Ana Miguel

Centre hospitalier universitaire de Caen, Caen, France; Hôpital privé de la Baie, Avranches, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2012 in Eye
Verified
Journal Article
Closed access
AMA I M Miguel
A I M Miguel
FHF Henriques
F Henriques
LALuís Azevedo
Luís Azevedo
ALA J R Loureiro
A J R Loureiro
DMD A L Maberley
D A L Maberley

4 July 2012 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
AMAna Miguel
Ana Miguel
LALuís Azevedo
Luís Azevedo
MAManuela Araújo
Manuela Araújo
APAltamiro Costa Pereira
Altamiro Costa Pereira

1 January 2017 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
AMA.I.M. Miguel
A.I.M. Miguel
ALA. Legris
A. Legris

6 February 2019 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
AMAna I M Miguel
Ana I M Miguel
ASAndré B Silva
André B Silva
LALuís Azevedo
Luís Azevedo
Background Compared with current imaging methods, the diagnostic performance and the advantages and limitations of optical coherence tomography angiography (OCTA) remain unclear. We performed a systematic review and meta-analysis of studies investigating vessel density (VD) in patients with glaucoma using OCTA. Methods We conducted a literature search on PubMed, Scopus, Web of Science, ISI Conference Proceedings and Google Scholar, along with a manual search, from January 2006 to March 2018. We included prospective studies that used OCTA to compare the VD in glaucomatous eyes with healthy control eyes. Results Of 3045 screened articles, 24 were included in a broad characterisation and 18 in the meta-analysis. We observed a statistically significant reduction in the mean peripapillary VD (MPVD) in glaucoma (MPVD: 57.53%, 95% CI 52.60 to 62.46, p< 0.001) compared with controls (MPVD: 65.47%, 95% CI 59.82 to 71.11; standardised mean difference [SMD], –1.41, 95% CI –1.62 to –1.20, p< 0.001) for 888 glaucomatous and 475 healthy eyes, and also in the mean-whole optic nerve image VD (SMD, –9.63, 95% CI –10.22 to –9.03, p<0.001), mean inside-disc VD (SMD, − 9.51, 95% CI –12.66 to –6.36, p<0.05) and mean parafoveal VD (SMD, –3.92, 95% CI –4.73 to –3.12, p<0.001). Subgroup analyses revealed a significant difference in the MPVD across glaucoma subtypes and OCTA devices. Conclusion This suggests the diagnostic utility of OCTA in detecting glaucomatous eyes; however, further longitudinal prospective studies are welcomed to characterise vascular changes in glaucoma.

15 January 2021 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
AMAna Miguel
Ana Miguel
ASAndré Silva
André Silva
JBJoao Barbosa-Breda
Joao Barbosa-Breda
LALuis Azevedo
Luis Azevedo
AAAbdulkarim Abdulrahman
Abdulkarim Abdulrahman
ISIngeborg Stalmans
Ingeborg Stalmans
Background/aims Optical coherence tomography angiography (OCTA) allows the study of vessel density (VD). We intended to perform a systematic review of studies focusing on longitudinal changes in peripapillary and macular VD measurements in glaucoma. Methods A search was performed across MEDLINE, Scopus, ISI Web of Science and Google Scholar, using the following query from inception until 20 September 2019: ((“optical coherence tomography angiography”[tiab]) OR (optical coherence tomography angiography[MeSH]) OR (“OCTA”[tiab]) OR (“OCT-A”[tiab]) OR (“angio-OCT”[tiab]) OR (“OCT- angiography”[tiab]) OR (“OCT-angio”[tiab]) OR (“OCT-angiographie”[tiab])) AND (glaucom*[tiab] OR glaucoma[MeSH]). Prospective studies that quantitatively assessed the longitudinal changes in VD in glaucoma with at least 3 months of follow-up were included. Results Ten out of 4516 studies were included. The rate of VD change in glaucoma varied from 0.036/year to 1.08/year and 1.3% to 3.2% per year, with significantly different rates between glaucoma and healthy controls. Five studies assessed VD change after glaucoma surgery, obtaining variable results, ranging from a temporary VD decrease to increase after 3 months. Meta-analysis was not possible due to a wide variation in methods, measurements and region of VD. Conclusion OCTA is a non-invasive technology, which shows promise in glaucoma. Measures should be taken to increase the quality and standardise the methodology of VD measures in OCTA longitudinal studies, for future meta-analyses.

1 October 2012 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
AMAna Miguel
Ana Miguel
LALuís Azevedo
Luís Azevedo
FLFernando Lopes
Fernando Lopes
AFAlberto Freitas
Alberto Freitas
APAltamiro Costa Pereira
Altamiro Costa Pereira